146 related articles for article (PubMed ID: 20422455)
1. Impact of US surveillance on detection of clinically occult locoregional recurrence after mastectomy for breast cancer.
Kim HJ; Kwak JY; Choi JW; Bae JH; Shin KM; Lee HJ; Kim GC; Jung JH; Park JY
Ann Surg Oncol; 2010 Oct; 17(10):2670-6. PubMed ID: 20422455
[TBL] [Abstract][Full Text] [Related]
2. US screening for detection of nonpalpable locoregional recurrence after mastectomy.
Lee JH; Kim EK; Oh JY; Kwon HC; Kim SH; Kim DC; Lee M; Cho SH; Nam KJ
Eur J Radiol; 2013 Mar; 82(3):485-9. PubMed ID: 23131395
[TBL] [Abstract][Full Text] [Related]
3. Value of ultrasound for postoperative surveillance of asian patients with history of breast cancer surgery: a single-center study.
Suh YJ; Kim MJ; Kim EK; Moon HJ; Kim SI; Park BW
Ann Surg Oncol; 2013 Oct; 20(11):3461-8. PubMed ID: 23695431
[TBL] [Abstract][Full Text] [Related]
4. Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.
Chen X; Yu X; Chen J; Zhang Z; Tuan J; Shao Z; Guo X; Feng Y
Cancer; 2013 Jul; 119(13):2366-74. PubMed ID: 23576181
[TBL] [Abstract][Full Text] [Related]
5. Locoregional recurrence after mastectomy with immediate transverse rectus abdominis myocutaneous (TRAM) flap reconstruction.
Patterson SG; Teller P; Iyengar R; Carlson GW; Gabram-Mendola SG; Losken A; Styblo T; Torres M; Wood WC; Perez SD; Mosunjac M; Rizzo M
Ann Surg Oncol; 2012 Aug; 19(8):2679-84. PubMed ID: 22476750
[TBL] [Abstract][Full Text] [Related]
6. Low risk of locoregional recurrence of primary breast carcinoma after treatment with a modification of the Halsted radical mastectomy and selective use of radiotherapy.
Bijker N; Rutgers EJ; Peterse JL; van Dongen JA; Hart AA; Borger JH; Kroon BB
Cancer; 1999 Apr; 85(8):1773-81. PubMed ID: 10223572
[TBL] [Abstract][Full Text] [Related]
7. A positive margin is not always an indication for radiotherapy after mastectomy in early breast cancer.
Truong PT; Olivotto IA; Speers CH; Wai ES; Berthelet E; Kader HA
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):797-804. PubMed ID: 14967436
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for locoregional recurrence after mastectomy in stage T1 N0 breast cancer.
Hastings J; Iganej S; Huang C; Huang R; Slezak J
Am J Clin Oncol; 2014 Oct; 37(5):486-91. PubMed ID: 23428949
[TBL] [Abstract][Full Text] [Related]
9. Limited value and utility of breast MRI in patients undergoing breast-conserving cancer surgery.
Shin HC; Han W; Moon HG; Yom CK; Ahn SK; You JM; Kim JS; Chang JM; Cho N; Moon WK; Park IA; Noh DY
Ann Surg Oncol; 2012 Aug; 19(8):2572-9. PubMed ID: 22446897
[TBL] [Abstract][Full Text] [Related]
10. A nomogram for predicting locoregional recurrence in primary breast cancer patients who received breast-conserving surgery after neoadjuvant chemotherapy.
Matsuda N; Hayashi N; Ohde S; Yagata H; Kajiura Y; Yoshida A; Suzuki K; Nakamura S; Tsunoda H; Yamauchi H
J Surg Oncol; 2014 Jun; 109(8):764-9. PubMed ID: 24647874
[TBL] [Abstract][Full Text] [Related]
11. [The importance of the follow-up in patients operated on for breast cancer. A retrospective analysis of 2482 cases].
Krengli M; Pastore G; Maffei S
Minerva Med; 1993; 84(7-8):409-15. PubMed ID: 8414134
[TBL] [Abstract][Full Text] [Related]
12. The role of US and MR imaging in detecting local chest wall tumor recurrence after mastectomy.
Yilmaz MH; Esen G; Ayarcan Y; Aydoğan F; Ozgüroğlu M; Demir G; Beşe N; Mandel NM
Diagn Interv Radiol; 2007 Mar; 13(1):13-8. PubMed ID: 17354188
[TBL] [Abstract][Full Text] [Related]
13. US surveillance of regional lymph node recurrence after breast cancer surgery.
Moon HJ; Kim MJ; Kim EK; Park BW; Youk JH; Kwak JY; Sohn J; Kim SI
Radiology; 2009 Sep; 252(3):673-81. PubMed ID: 19546429
[TBL] [Abstract][Full Text] [Related]
14. Ten-year locoregional recurrence risks in women with nodal micrometastatic breast cancer staged with axillary dissection.
Lupe K; Truong PT; Alexander C; Speers C; Tyldesley S
Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):e681-8. PubMed ID: 21300456
[TBL] [Abstract][Full Text] [Related]
15. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes.
Truong PT; Berthelet E; Lee J; Kader HA; Olivotto IA
Cancer; 2005 May; 103(10):2006-14. PubMed ID: 15812825
[TBL] [Abstract][Full Text] [Related]
16. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy.
Margalit DN; Sreedhara M; Chen YH; Catalano PJ; Nguyen PL; Golshan M; Overmoyer BA; Harris JR; Brock JE
Ann Surg Oncol; 2013 Mar; 20(3):811-8. PubMed ID: 22956068
[TBL] [Abstract][Full Text] [Related]
17. Phyllodes tumors of the breast: a case series of 106 patients.
Ben Hassouna J; Damak T; Gamoudi A; Chargui R; Khomsi F; Mahjoub S; Slimene M; Ben Dhiab T; Hechiche M; Boussen H; Rahal K
Am J Surg; 2006 Aug; 192(2):141-7. PubMed ID: 16860620
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors affecting the outcome of salvage radiotherapy for isolated locoregional recurrence after mastectomy.
Kim K; Chie EK; Han W; Noh DY; Oh DY; Im SA; Kim TY; Bang YJ; Ha SW
Am J Clin Oncol; 2010 Feb; 33(1):23-7. PubMed ID: 19704369
[TBL] [Abstract][Full Text] [Related]
19. Loco-regional recurrence after mastectomy in high-risk breast cancer--risk and prognosis. An analysis of patients from the DBCG 82 b&c randomization trials.
Nielsen HM; Overgaard M; Grau C; Jensen AR; Overgaard J
Radiother Oncol; 2006 May; 79(2):147-55. PubMed ID: 16647152
[TBL] [Abstract][Full Text] [Related]
20. Ultrasonographic detection of occult cancer in patients after surgical therapy for breast cancer.
Shin JH; Han BK; Choe YH; Nam SJ; Park W; Im YH
J Ultrasound Med; 2005 May; 24(5):643-9. PubMed ID: 15840796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
